RAJAF — Cordyceps Sunshine Biotech Holdings Co Share Price
Last trade - 00:00- $951.19m
- $951.60m
- $0.88m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 8,732.75 | ||
| Price to Sales | 1,160.9 | ||
| EV to EBITDA | 3,632.74 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 45.72% | ||
| Return on Equity | n/a | ||
| Operating Margin | 25.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 0.13 | n/a | 0.05 | 0.88 | n/a | n/a | 87.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cordyceps Sunshine Biotech Holdings Co Ltd is a Taiwan-based company mainly engaged in the cultivation and sales of cordyceps. The primary product is Cordyceps, Ophiocordyceps Sinensis, a valuable Chinese medicinal material with a long history of application in China. The Company produces two kinds of Cordyceps, including dry Cordyceps and fresh Cordyceps. Dry cordyceps has a long shelf life and is convenient to store and carry, fresh Cordyceps has a short shelf life and is inconvenient to store and carry. The products are cultivated in its breeding center. The Company commissioned third party quality testing institution to perform quality testing for products to ensure quality control.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 4th, 2020
- Public Since
- October 9th, 2023
- No. of Shareholders
- 92
- No. of Employees
- 15
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 111,120,000
- Address
- 6F, No.15, Lane 548, TAIPEI, 114
- Web
- https://cordyceps-sunshine.com/
- Phone
- +886 227489091
- Auditors
- Keith K. Zhen, CPA
Similar to RAJAF
23andMe Holding Co
Pink Sheets on Nasdaq
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
FAQ
As of Today at 24:16 UTC, shares in Cordyceps Sunshine Biotech Holdings Co are trading at $9.22. This share price information is delayed by 15 minutes.
Shares in Cordyceps Sunshine Biotech Holdings Co last closed at $9.22 and the price had moved by over the past 365 days. In terms of relative price strength the Cordyceps Sunshine Biotech Holdings Co share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreCordyceps Sunshine Biotech Holdings Co does not currently pay a dividend.
Cordyceps Sunshine Biotech Holdings Co does not currently pay a dividend.
Cordyceps Sunshine Biotech Holdings Co does not currently pay a dividend.
To buy shares in Cordyceps Sunshine Biotech Holdings Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $9.22, shares in Cordyceps Sunshine Biotech Holdings Co had a market capitalisation of $1.02bn.
Here are the trading details for Cordyceps Sunshine Biotech Holdings Co:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: RAJAF
Based on an overall assessment of its quality, value and momentum Cordyceps Sunshine Biotech Holdings Co is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cordyceps Sunshine Biotech Holdings Co. Over the past six months, its share price has outperformed the S&P500 Index by +22194.7%.
As of the last closing price of $9.22, shares in Cordyceps Sunshine Biotech Holdings Co were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cordyceps Sunshine Biotech Holdings Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $9.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Cordyceps Sunshine Biotech Holdings Co's directors